| 2023/01/26 22:26:27 | |
|---|---|
| Price | |
| 67.01 EUR | |
| Difference | -0.01% (-0.01) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 142,466 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 66.53 EUR (151) |
| Ask (Ask size) | 67.52 EUR (148) |
| Open | 66.59 EUR |
| High | 67.82 EUR |
| Low | 66.24 EUR |
| Close (prev. day) | 67.02 EUR |
| VWAP | 66.91991 EUR |
| Volume (pcs) | 12,179 |
| Trading volume | 815,017.55 |
| Number of trades | 60 |
| Last size | - |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/01/09 |
|
Global Equity Ratings |
|
| 2022/12/19 |
|
Global Equity Ratings |
|
| 2022/11/28 |
|
Global Equity Ratings |
|
| 2022/11/18 |
|
Global Equity Ratings |
|
| 2022/10/31 |
|
Global Equity Ratings |
|
| 2023/01/26 22:26:27 | |
|---|---|
| Price | |
| 67.01 EUR | |
| Difference | -0.01% (-0.01) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 142,466 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 66.53 EUR (151) |
| Ask (Ask size) | 67.52 EUR (148) |
| Open | 66.59 EUR |
| High | 67.82 EUR |
| Low | 66.24 EUR |
| Close (prev. day) | 67.02 EUR |
| VWAP | 66.91991 EUR |
| Volume (pcs) | 12,179 |
| Trading volume | 815,017.55 |
| Number of trades | 60 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -7.81% | +21.04% | +15.16% |
| Perf (abs.) | -5.68 | +11.65 | +8.82 |
| Beta | 0.26 | 0.29 | 0.49 |
| Volatility | 23.26 | 21.38 | 24.14 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 67.25 EUR (3,720) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 67.86 EUR (2,534) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 72.28 EUR (2,159) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 70.54 EUR (3,049) |
| YTD High | date | 69.23 EUR (2023/01/06) |
| YTD Low | date | 65.15 EUR (2023/01/10) |
| 52 Weeks High | date | 80.87 EUR (2022/11/09) |
| 52 Weeks Low | date | 54.84 EUR (2022/01/27) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/01/26 | 17:35 | 66.45 EUR | 0.07 | 14 |
| Vienna Stock Exchange | 2023/01/26 | 17:32 | 66.42 EUR | 0.00 | 2 |
| Tradegate | 2023/01/26 | 22:26 | 67.01 EUR | 0.82 | 60 |
| Stuttgart | 2023/01/27 | 08:04 | 66.53 EUR | 0.00 | 1 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| NYSE | 2023/01/26 | 22:00 | 72.99 USD | 474.13 | 62,927 |
| Munich | 2023/01/27 | 08:05 | 66.59 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2023/01/26 | 17:39 | 72.06 USD | 0.02 | 5 |
| Hanover | 2023/01/27 | 08:02 | 66.71 EUR | 0.00 | 1 |
| Hamburg | 2023/01/27 | 08:02 | 66.71 EUR | 0.00 | 1 |
| Frankfurt | 2023/01/26 | 16:57 | 66.50 EUR | 0.18 | 6 |
| Duesseldorf | 2023/01/26 | 21:00 | 66.38 EUR | 0.00 | 12 |
| Berlin | 2023/01/27 | 08:05 | 66.54 EUR | 0.00 | 1 |
| BX Swiss | - | - | - | 0.00 | - |
Company Logo
Contact Details
| BRISTOL MYERS SQUIBB CO. |
| - - |
| 430 East 29th Street - 10016 New York |
| Telefon: 1-212-546-4000 |
| Fax: - |
| E-mail: - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |
Members of Management Board
| Deepak Bhatt | Member of Board of Directors |
| Julia Haller | Member of Board of Directors |
| Karen Vousden | Member of Board of Directors |
| Manuel Hidalgo Medina | Member of Board of Directors |
| Derica Rice | Member of Board of Directors |
| Gerald Storch | Member of Board of Directors |
| Paula Price | Member of Board of Directors |
| Peter Arduini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Theodore Samuels | Member of Board of Directors |
| Giovanni Caforio | Chairman of Managing Board |
| Christopher Boerner | Member of Executive Committee |
| Adam Dubow | Member of Executive Committee |
| Ann M. Powell | Member of Executive Committee |
| Catalina Vargas | Member of Executive Committee |
| David Elkins | Member of Executive Committee |
| Elizabeth A. Mily | Member of Executive Committee |
| Lou Schmukler | Member of Executive Committee |
| Michelle Weese | Member of Executive Committee |
| Paul von Autenried | Member of Executive Committee |
| Rupert Vessey | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Sandra Leung | Member of Executive Committee |